Proposed Data Collection Submitted for Public Comment and Recommendations, 64474-64475 [2020-22491]
Download as PDF
<![CDATA[
64474
Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0931; Docket No. CDC–2020–
0106]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Blood Lead Surveillance System
(BLSS)’’ (OMB Control No. 0920–0931,
Exp. Date 05/31/2021). The National
Center for Environmental Health
(NCEH) is leading a three-year extension
information collection request (ICR) for
two CDC information collections, one
for childhood blood lead surveillance by
NCEH and another for adult blood lead
surveillance by the National Institute for
Occupational Safety and Health
(NIOSH).
SUMMARY:
CDC must receive written
comments on or before December 14,
2020.
DATES:
You may submit comments,
identified by Docket No. CDC–2020–
0106 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
18:52 Oct 09, 2020
Jkt 253001
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Blood Lead Surveillance System
(OMB Control No. 0920–0931, Exp. Date
05/31/2021)—Extension—National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
This is a request for a three-year
Extension for an existing Paperwork
Reduction Act (PRA) clearance titled
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
‘‘Blood Lead Surveillance System
(BLSS)’’ (OMB Control No.0920–0931;
Expiration date 05/31/2021). The
National Center for Environmental
Health (NCEH) is leading this ICR for
two Centers for Disease Control and
Prevention (CDC) information
collections, one for childhood blood
lead surveillance by NCEH and another
for adult blood lead surveillance by the
National Institute for Occupational
Safety and Health (NIOSH).
The goal of the NCEH Childhood
Blood Lead Surveillance (CBLS)
Program is to support blood lead
screening and to promote primary
prevention of exposure to lead. Also, the
CBLS Program supports secondary
prevention of adverse health effects
when lead exposures occur in children,
through improved program management
and oversight in respondent
jurisdictions.
The goal of the NIOSH Adult Blood
Lead Epidemiology and Surveillance
(ABLES) Program is to build state
capacity for adult blood lead
surveillance programs to measure trends
in adult blood lead levels and to prevent
lead over-exposures.
NCEH has a three-year cooperative
agreement, titled ‘‘Lead Poisoning
Prevention—Childhood Lead Poisoning
Prevention—financed partially by
Prevention and Public Health Funds’’
(Funding Opportunity Announcement
[FOA] No. CDC–RFA–EH17–
1701PPHF17) and a two-year
cooperative agreement, titled
‘‘Childhood Lead Poisoning Prevention
Projects, State and Local Childhood
Lead Poisoning Prevention and
Surveillance of Blood Lead Levels in
Children’’—(Notice of Funding
Opportunity [NOFO] No. CDC–RFA–
EH18–1806). Both have one-year
extensions (CDC–RFA–EH17–
1701SUPP20 and CDC–RFA–EH18–
1806 SUPP20, respectively). The first
year of this ICR will extend through the
first eight months of FY21 and thus will
be covered by the one-year extensions,
while funding for the second and third
years of this ICR will be determined in
the future. Data submission to the
ABLES Program is voluntary and
completed through data sharing
agreements with state agencies or their
bona fide agents.
Blood lead surveillance over the
human lifespan is covered under this
single ICR, specifically for children
younger than 16 years through CBLS at
NCEH, and for adults 16 years and
E:\FR\FM\13OCN1.SGM
13OCN1
64475
Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
older, through ABLES at NIOSH. Over
the past several decades there have been
substantial efforts in environmental lead
abatement, improved protection from
occupational lead exposure, and a
reduction in the prevalence of
population blood lead levels (BLLs) over
time. The U.S. population BLLs have
substantially decreased over the last
four decades. For example, the CDC has
reported the 1976–1980 U.S. mean BLL
in children 6 months to 5 years was 16.0
micrograms per deciliter (mcg/dL), and
14.1 mcg/dL among adults 18 to 74
years. More recently, the CDC reported
the 2009–2010 U.S. BLL geometric
elevated BLLs when primary prevention
is not achieved. As of 2015, NCEH
defines its reference level for children at
5 mcg/dL. NIOSH defines an elevated
BLLs as greater than or equal to 5 mcg/
dL for adults.
Respondents are defined as state,
local, and territorial health departments
with lead poisoning prevention
programs. The estimated annual time
burden for NCEH CBLS is 946 hours.
The estimated annual time burden for
NIOSH ABLES is 280 hours. In total,
CDC is requesting approval for a total
annual time burden of 1,226 hours.
means among children 1 to 5 years and
among adults 20 years and older as 1.2
mcg/dL for both age groups.
In 2012, the National Toxicology
Program (NTP) concluded that there is
sufficient evidence that even BLLs less
than 5 mcg/dL are associated with
adverse health effects in both children
and adults. Despite the reduction in the
overall population BLL over four
decades, lead exposures continue to
occur at unacceptable levels for
individuals in communities and
workplaces across the nation.
Surveillance will continue through
CBLS and ABLES to identify cases of
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hr)
Total burden
(in hr)
Form name
State, Local and Territorial Health
Departments, or their Bona Fide
Agents.
CBLS Variables (ASCII Text Files) ..
CBLS Aggregate Records Form
(Excel).
ABLES Case Records Form and
Brief Narrative Report.
ABLES Aggregate Records Form
and Brief Narrative Report.
59
1
4
1
4
2
944
2
32
1
8
256
8
1
3
24
...........................................................
........................
........................
........................
1,226
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–22491 Filed 10–9–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0888; Docket No. CDC–2020–
0102]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondent
VerDate Sep<11>2014
18:52 Oct 09, 2020
Jkt 253001
proposed information collection project
titled Factors Influencing the
Transmission of Influenza. This
proposed collection is intended to
further our understanding of how
respiratory viruses like influenza are
transmitted from person to person.
DATES: CDC must receive written
comments on or before December 14,
2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0102 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
E:\FR\FM\13OCN1.SGM
13OCN1
]]>Agencies
[Federal Register Volume 85, Number 198 (Tuesday, October 13, 2020)]
[Notices]
[Pages 64474-64475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22491]
[[Page 64474]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-0931; Docket No. CDC-2020-0106]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Blood Lead Surveillance System
(BLSS)'' (OMB Control No. 0920-0931, Exp. Date 05/31/2021). The
National Center for Environmental Health (NCEH) is leading a three-year
extension information collection request (ICR) for two CDC information
collections, one for childhood blood lead surveillance by NCEH and
another for adult blood lead surveillance by the National Institute for
Occupational Safety and Health (NIOSH).
DATES: CDC must receive written comments on or before December 14,
2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0106 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7118; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Blood Lead Surveillance System (OMB Control No. 0920-0931, Exp.
Date 05/31/2021)--Extension--National Center for Environmental Health
(NCEH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
This is a request for a three-year Extension for an existing
Paperwork Reduction Act (PRA) clearance titled ``Blood Lead
Surveillance System (BLSS)'' (OMB Control No.0920-0931; Expiration date
05/31/2021). The National Center for Environmental Health (NCEH) is
leading this ICR for two Centers for Disease Control and Prevention
(CDC) information collections, one for childhood blood lead
surveillance by NCEH and another for adult blood lead surveillance by
the National Institute for Occupational Safety and Health (NIOSH).
The goal of the NCEH Childhood Blood Lead Surveillance (CBLS)
Program is to support blood lead screening and to promote primary
prevention of exposure to lead. Also, the CBLS Program supports
secondary prevention of adverse health effects when lead exposures
occur in children, through improved program management and oversight in
respondent jurisdictions.
The goal of the NIOSH Adult Blood Lead Epidemiology and
Surveillance (ABLES) Program is to build state capacity for adult blood
lead surveillance programs to measure trends in adult blood lead levels
and to prevent lead over-exposures.
NCEH has a three-year cooperative agreement, titled ``Lead
Poisoning Prevention--Childhood Lead Poisoning Prevention--financed
partially by Prevention and Public Health Funds'' (Funding Opportunity
Announcement [FOA] No. CDC-RFA-EH17-1701PPHF17) and a two-year
cooperative agreement, titled ``Childhood Lead Poisoning Prevention
Projects, State and Local Childhood Lead Poisoning Prevention and
Surveillance of Blood Lead Levels in Children''--(Notice of Funding
Opportunity [NOFO] No. CDC-RFA-EH18-1806). Both have one-year
extensions (CDC-RFA-EH17-1701SUPP20 and CDC-RFA-EH18-1806 SUPP20,
respectively). The first year of this ICR will extend through the first
eight months of FY21 and thus will be covered by the one-year
extensions, while funding for the second and third years of this ICR
will be determined in the future. Data submission to the ABLES Program
is voluntary and completed through data sharing agreements with state
agencies or their bona fide agents.
Blood lead surveillance over the human lifespan is covered under
this single ICR, specifically for children younger than 16 years
through CBLS at NCEH, and for adults 16 years and
[[Page 64475]]
older, through ABLES at NIOSH. Over the past several decades there have
been substantial efforts in environmental lead abatement, improved
protection from occupational lead exposure, and a reduction in the
prevalence of population blood lead levels (BLLs) over time. The U.S.
population BLLs have substantially decreased over the last four
decades. For example, the CDC has reported the 1976-1980 U.S. mean BLL
in children 6 months to 5 years was 16.0 micrograms per deciliter (mcg/
dL), and 14.1 mcg/dL among adults 18 to 74 years. More recently, the
CDC reported the 2009-2010 U.S. BLL geometric means among children 1 to
5 years and among adults 20 years and older as 1.2 mcg/dL for both age
groups.
In 2012, the National Toxicology Program (NTP) concluded that there
is sufficient evidence that even BLLs less than 5 mcg/dL are associated
with adverse health effects in both children and adults. Despite the
reduction in the overall population BLL over four decades, lead
exposures continue to occur at unacceptable levels for individuals in
communities and workplaces across the nation. Surveillance will
continue through CBLS and ABLES to identify cases of elevated BLLs when
primary prevention is not achieved. As of 2015, NCEH defines its
reference level for children at 5 mcg/dL. NIOSH defines an elevated
BLLs as greater than or equal to 5 mcg/dL for adults.
Respondents are defined as state, local, and territorial health
departments with lead poisoning prevention programs. The estimated
annual time burden for NCEH CBLS is 946 hours. The estimated annual
time burden for NIOSH ABLES is 280 hours. In total, CDC is requesting
approval for a total annual time burden of 1,226 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hr) (in hr)
----------------------------------------------------------------------------------------------------------------
State, Local and Territorial CBLS Variables 59 4 4 944
Health Departments, or their (ASCII Text 1 1 2 2
Bona Fide Agents. Files).
CBLS Aggregate
Records Form
(Excel).
ABLES Case 32 1 8 256
Records Form
and Brief
Narrative
Report.
ABLES Aggregate 8 1 3 24
Records Form
and Brief
Narrative
Report.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,226
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-22491 Filed 10-9-20; 8:45 am]
BILLING CODE 4163-18-P
